| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Monday - Mar 21, 2022 |
|||||||||
| Q3 FY22 | $0.87 | $0.71 | $10.87B | $10.60B |
NYSE |
||||
|
FAT Brands
FAT
|
- | -$1.16 | -$0.29 | $74.19M | $57.50M |
NASDAQ |
|||
|
Dave
DAVE
|
Q4 FY21 | -$4.79 | - | $40.20M | - |
NASDAQ |
|||
|
Bowman Consulting Group
BWMN
|
- | -$0.07 | -$0.07 | $41.93M | $34.50M |
NASDAQ |
|||
|
Nortech Systems
NSYS
|
Q4 FY21 | $0.03 | - | $33.46M | - |
NASDAQ |
|||
|
Parke Bancorp
PKBK
|
- | $0.83 | - | $21.84M | - |
NASDAQ |
|||
|
Sonim Technologies
SONM
|
- | -$3.60 | -$4.00 | $15.93M | $18.25M |
NASDAQ |
|||
|
UroGen Pharma
URGN
|
Q4 FY21 | -$1.27 | -$1.18 | $16.17M | $16.24M |
NASDAQ |
|||
|
Canterbury Park Holding
CPHC
|
- | $1.37 | - | $13.96M | - |
NASDAQ |
|||
|
Crexendo
CXDO
|
Q4 FY21 | $0.02 | $0.03 | $9M | $8.82M |
NASDAQ |
|||
|
TELA Bio
TELA
|
Q4 FY21 | -$0.59 | -$0.54 | $8.37M | $7.97M |
NASDAQ |
|||
|
Chicago Rivet & Machine
CVR
|
- | $0.08 | - | $7.75M | - |
AMEX |
|||
|
Caribou Biosciences
CRBU
|
- | -$0.34 | -$0.34 | $2.56M | $4.17M |
NASDAQ |
|||
|
Marinus Pharmaceuticals
MRNS
|
Q4 FY21 | -$0.77 | -$0.81 | $1.52M | $3.37M |
NASDAQ |
|||
|
authID
AUID
|
Q4 FY21 | -$2.48 | - | $597.17K | - |
NASDAQ |
|||
|
NEXGEL
NXGL
|
- | -$0.29 | -$0.37 | $533K | $419K |
NASDAQ |
|||
|
Ainos
AIMD
|
- | -$0.01 | - | $26.40K | - |
NASDAQ |
|||
|
Lixte Biotechnology Holdings
LIXT
|
- | -$1.50 | - | - | - |
NASDAQ |
|||
|
Cellectar Biosciences
CLRB
|
- | -$1.00 | -$1.00 | - | - |
NASDAQ |
|||
|
Indaptus Therapeutics
INDP
|
- | -$0.22 | -$0.90 | - | - |
NASDAQ |
|||
|
Greenwich LifeSciences
GLSI
|
- | -$0.18 | -$0.07 | - | - |
NASDAQ |
|||
|
Compass Therapeutics
CMPX
|
- | -$0.15 | -$0.07 | - | - |
NASDAQ |
|||
|
ORIC Pharmaceuticals
ORIC
|
Q4 FY21 | -$0.58 | -$0.61 | - | - |
NASDAQ |
|||
| Show 13 more companies | |||||||||
